1,664
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis

ORCID Icon, , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon & show all
Article: 1854519 | Received 10 Sep 2020, Accepted 18 Nov 2020, Published online: 10 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xinghan Liu, Yujun Xu, Lijie Yin, Yayi Hou & Shuli Zhao. (2021) Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl2 Inhibit Melanoma via Regulating Macrophage Polarization and Dendritic Cell Maturation. International Journal of Nanomedicine 16, pages 5675-5692.
Read now

Articles from other publishers (13)

Pascale Mariani, Nouritza Torossian, Steven van Laere, Peter Vermeulen, Leanne de Koning, Sergio Roman-Roman, Olivier Lantz, Manuel Rodrigues, Marc-Henri Stern, Sophie Gardrat, Laetitia Lesage, Gabriel Champenois, André Nicolas, Alexandre Matet, Nathalie Cassoux, Vincent Servois, Emanuela Romano, Sophie Piperno-Neumann, Claire Lugassy & Raymond Barnhill. (2023) Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases. British Journal of Cancer 129:5, pages 772-781.
Crossref
Sebastian Liau, Janney Z. Wang, Ethan Zagarella, Paus Paulus, Nguyen Huong Que Hiep Dang, Tristan Rawling, Michael Murray & Fanfan Zhou. (2023) An update on inflammation in uveal melanoma. Biochimie 212, pages 114-122.
Crossref
Bingran Yu, Ning Zhang, Yun Feng, Weiqi Xu, Ti Zhang & Lu Wang. (2023) A gene mutation-based risk model for prognostic prediction in liver metastases. BMC Genomics 24:1.
Crossref
Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, Charlotta All-Eriksson, Christian Cahlin, Nils Elander, Hildur Helgadottir, Jens Folke Kiilgaard, Sara Kinhult, Ingrid Ljuslinder, Jan Mattsson, Magnus Rizell, Malin Sternby Eilard, Gustav J. Ullenhag, Jonas A. Nilsson, Lars Ny & Per Lindnér. (2023) Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial). Journal of Clinical Oncology 41:16, pages 3042-3050.
Crossref
Adriana Amaro, Francesco Reggiani, Daniela Fenoglio, Rosaria Gangemi, Anna Tosi, Alessia Parodi, Barbara Banelli, Valentina Rigo, Luca Mastracci, Federica Grillo, Alessandra Cereghetti, Aizhan Tastanova, Adhideb Ghosh, Fabio Sallustio, Laura Emionite, Antonio Daga, Tiziana Altosole, Gilberto Filaci, Antonio Rosato, Mitchell Levesque, Michele Maio, Ulrich Pfeffer & Michela Croce. (2023) Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
T. M. L. Tong, M. C. Burgmans, F. M. Speetjens, A. R. van Erkel, R. W. van der Meer, C. S. P. van Rijswijk, M. A. Jonker-Bos, C. F. M. Roozen, M. Sporrel-Blokland, J. Lutjeboer, E. L. van Persijn van Meerten, C. H. Martini, R. W. M. Zoethout, F. G. J. Tijl, C. U. Blank & E. Kapiteijn. (2023) Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial. CardioVascular and Interventional Radiology 46:3, pages 350-359.
Crossref
T. M. L. Tong, M. K. van der Kooij, F. M. Speetjens, A. R. van Erkel, R. W. van der Meer, J. Lutjeboer, E. L. van Persijn van Meerten, C. H. Martini, R. W. M. Zoethout, F. G. J. Tijl, C. U. Blank, M. C. Burgmans & E. Kapiteijn. (2022) Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial. Trials 23:1.
Crossref
Qiujun Zhou, Tingting Fang, Shenyu Wei, Shiqian Chai, Huifeng Yang, Maocan Tao & Yi Cao. (2022) Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review). Experimental and Therapeutic Medicine 24:4.
Crossref
S. V. Saakyan, L. A. Katargina, E. B. Myakoshina, G. P. Zakharova, I. P. Khoroshilova–Maslova & A. M. Maibogin. (2022) Immunohistochemical study of uveal melanoma and its cellular microenvironment. Advances in Molecular Oncology 9:2, pages 97-104.
Crossref
Xiaochen Ma, Sejie Yu, Bin Zhao, Wei Bai, Yubo Cui, Jinglan Ni, Qinghua Lyu & Jun Zhao. (2022) Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma. Frontiers in Immunology 13.
Crossref
Ernesto Rossi, Michela Croce, Francesco Reggiani, Giovanni Schinzari, Marianna Ambrosio, Rosaria Gangemi, Giampaolo Tortora, Ulrich Pfeffer & Adriana Amaro. (2021) Uveal Melanoma Metastasis. Cancers 13:22, pages 5684.
Crossref
Juliana Maria Motta, Vivian Mary Rumjanek, Alberto Mantovani & Massimo Locati. (2021) Tumor-Released Products Promote Bone Marrow-Derived Macrophage Survival and Proliferation. Biomedicines 9:10, pages 1387.
Crossref
Mariarosaria Marseglia, Adriana Amaro, Nicola Solari, Rosaria Gangemi, Elena Croce, Enrica Teresa Tanda, Francesco Spagnolo, Gilberto Filaci, Ulrich Pfeffer & Michela Croce. (2021) How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma. Cancers 13:9, pages 2043.
Crossref